STOCK TITAN

European Wax Center, Inc. (EWCZ) Financials

EWCZ
FY2026 annual
Revenue Not reported for FY2026
Net Income $8.7M -17.0% YoY
Free Cash Flow $50.1M -10.5% YoY
Operating Cash Flow $53.0M -6.2% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Apr 4, 2026 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q1 FY2027, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EWCZ SEC filings page.

This page shows European Wax Center, Inc. (EWCZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EWCZ FY2026

European Wax Center converts modest reported earnings into much larger cash generation, while capital returns and leverage make equity more sensitive.

From FY2024 through FY2026, operating cash flow stayed near $53M to $57M while net income remained around $9M to $10M, so reported earnings understate the cash produced by operations. Because free cash flow also stayed close to operating cash flow, capital spending is not absorbing the cash conversion; the larger gap is between accounting profit and cash generation.

Capital intensity is light: FY2026 capital expenditures were $2.9M against operating cash flow of $53.0M, leaving most internally generated cash available for financing decisions rather than reinvestment.

The capital structure became more equity-sensitive before the latest debt figure disappeared: debt-to-equity climbed from 3.4x in FY2024 to 4.3x in FY2025 as equity contracted. FY2026 financing cash flow was -$23.8M and share buybacks were $6.1M, showing cash continued flowing beyond day-to-day operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

European Wax Center, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Earnings Quality Cash-Backed
6.10x

For every $1 of reported earnings, European Wax Center, Inc. generates $6.10 in operating cash flow ($53.0M OCF vs $8.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
$960K
YoY-44.7%

European Wax Center, Inc. reported $960K in net income in Q1 2027. This represents a decrease of 44.7% from the same quarter a year earlier.

Revenue

Not reported for Q1 2027.

EBITDA

Not reported for Q1 2027.

EPS (Diluted)

Not reported for Q1 2027.

Cash & Balance Sheet

Free Cash Flow
-$1.1M
YoY-109.1%
QoQ-115.5%

European Wax Center, Inc. recorded an outflow of $1.1M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 109.1% from the same quarter a year earlier. Against the prior quarter it is down 115.5%.

Cash & Debt

Not reported for Q1 2027.

Dividends Per Share

Not reported for Q1 2027.

Shares Outstanding

Not reported for Q1 2027.

Margins & Returns

Return on Equity
0.9%
YoY-0.9pp

European Wax Center, Inc.'s ROE was 0.9% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the same quarter a year earlier.

Gross Margin

Not reported for Q1 2027.

Operating Margin

Not reported for Q1 2027.

Net Margin

Not reported for Q1 2027.

Capital Allocation

Share Buybacks
$0
YoY-100.0%

European Wax Center, Inc. repurchased no shares in Q1 2027. This represents a decrease of 100.0% from the same quarter a year earlier.

Capital Expenditures
$1.7M
YoY+158.9%
QoQ+131.3%

European Wax Center, Inc. invested $1.7M in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 158.9% from the same quarter a year earlier. Against the prior quarter it is up 131.3%.

R&D Spending

Not reported for Q1 2027.

EWCZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EWCZ quarterly income statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-Q
Operating IncomeN/AN/AN/AN/AN/AN/AN/A$14.3M
EBITDAN/AN/AN/AN/AN/AN/AN/A$19.4M
Income TaxN/AN/AN/AN/AN/AN/AN/A$1.7M
Net Income$960K-44.7%N/A$3.8M+155.5%$3.8M-11.7%$1.7M-37.3%N/A$1.5M-48.7%$4.2M+5.9%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

EWCZ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EWCZ quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-Q
GoodwillN/A$39.1M0.0%N/AN/AN/A$39.1M0.0%N/AN/A
Long-Term DebtN/AN/AN/AN/AN/A$390.0M-1.0%N/AN/A
Total Equity$106.7M+8.3%$104.9M+14.5%$104.8M+7.1%$105.9M-8.2%$98.5M-16.8%$91.6M-20.4%$97.9M-26.8%$115.3M-14.6%

Not reported in any period shown, so not listed: Total Assets, Current Assets, Cash & Equivalents, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Total Liabilities, Current Liabilities, Non-Current Liabilities, Retained Earnings.

EWCZ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EWCZ quarterly cash flow statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-Q
Operating Cash Flow$618K-95.1%$7.8M-52.9%$17.3M+16.8%$15.2M+5.5%$12.7M+18.5%$16.6M-1.1%$14.8M-16.0%$14.4M-15.4%
Depreciation & Amortization$5.4M+8.3%$5.4M+6.8%$5.0M-0.6%$5.0M-1.5%$5.0M-2.2%$5.0M-1.6%$5.1M-1.2%$5.1M+0.7%
Stock-Based Compensation$1.9M-26.6%N/AN/AN/A$2.6M+85.5%N/AN/AN/A
Capital Expenditures$1.7M+158.9%$739K+201.6%$810K+1227.9%$703K+280.0%$660K+2100.0%$245K+2127.3%$61K-59.6%$185K-30.2%
Free Cash Flow-$1.1M-109.1%$7.1M-56.8%$16.5M+11.8%$14.5M+1.9%$12.0M+12.7%$16.3M-2.5%$14.8M-15.6%$14.2M-15.2%
Investing Cash Flow-$1.7M-158.9%-$739K-201.6%-$810K-1227.9%-$703K-280.0%-$660K-728.6%-$245K-2127.3%-$61K+59.6%-$185K+30.2%
Financing Cash Flow-$3.2M+6.3%-$4.6M+68.6%-$6.8M+69.6%-$8.9M+52.8%-$3.5M-8.6%-$14.6M+47.8%-$22.4M-167.7%-$18.9M-140.8%
Share Buybacks$0-100.0%$0-100.0%$4.6M-76.9%$383K-96.2%$1.1M$10.0M-57.5%$20.1M+263.0%$10.0M

Not reported in any period shown, so not listed: Dividends Paid.

EWCZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EWCZ quarterly financial ratios
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-Q
Return on Equity0.9%-0.9ppN/A3.6%+2.1pp3.5%-0.2pp1.8%-0.6ppN/A1.5%-0.6pp3.7%+0.7pp
Debt-to-EquityN/AN/AN/AN/AN/A4.26+0.8xN/AN/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Assets, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
European Wax Center, Inc. EWCZ FY2026 N/A $8.7M N/A $319.4M —
Waldencast plc WALD FY2025 $272.1M -$229.7M -84.4% $111.9M 39/100
Acme United Corporation ACU FY2025 $196.5M $10.2M 5.2% $239.6M 59/100
Big Tree Cloud Holdings Limited DSY FY2025 $2.6M -$32.5M N/A $16.0M 8/100
Grove Collaborative Holdings, Inc. GROV FY2025 $173.7M -$11.7M -6.7% $43.1M 35/100
SkinHealth Systems Inc. SKIN FY2025 $300.8M -$9.5M -3.2% $68.3M 29/100

Frequently Asked Questions

Is European Wax Center, Inc. profitable?

Yes, European Wax Center, Inc. (EWCZ) reported a net income of $8.7M in fiscal year 2026.

Does European Wax Center, Inc. pay dividends?

Yes, European Wax Center, Inc. (EWCZ) paid $3.30 per share in dividends during fiscal year 2026.

What is European Wax Center, Inc.'s return on equity (ROE)?

European Wax Center, Inc. (EWCZ) has a return on equity of 8.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

European Wax Center, Inc. (EWCZ) generated $50.1M in free cash flow during fiscal year 2026. This represents a -10.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

European Wax Center, Inc. (EWCZ) generated $53.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

European Wax Center, Inc. (EWCZ) invested $2.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, European Wax Center, Inc. (EWCZ) spent $6.1M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

European Wax Center, Inc. (EWCZ) has an earnings quality ratio of 6.10x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top